Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 148 publications
BCL6 is required for the development of functionally responsive IgM+ GC Tfh-independent memory B cells.
Journal: The Journal of experimental medicine
Published: November 10, 2025
Integrins in engraftment of ex vivo generated plasma cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 08, 2025
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function.
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function.
Journal: Molecular therapy. Advances
Published: September 25, 2025
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function.
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Journal: Blood advances
Published: July 02, 2025
Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report.
Journal: Blood advances
Published: July 02, 2025
Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 27, 2025
Treatment of canine hemophilia A via intraosseous delivery of a platelet-specific factor VIII-lentiviral vector.
Journal: Blood vessels, thrombosis & hemostasis
Published: April 21, 2025
Engineering B cells to treat and study human disease.
Journal: Nature biotechnology
Published: February 12, 2025
HLA-A2 CAR/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function.
Journal: Molecular therapy. Methods & clinical development
Published: January 08, 2025
Innate-like memory T cells rapidly emerge in humans after gene therapy for SCID-X1.
Journal: Immunity
Published: October 03, 2024
Last Updated: 09/26/2026